Gilead Sciences Inc.
Andrew D Dickinson (Chief Financial Officer) sells GILD shares
AI-generated summary
Chief Financial Officer Andrew D Dickinson sold 3,000 shares of Gilead Sciences Inc. common stock on October 15, 2026, at an average price of $156.22 for a total value of $468,660. The transaction was made under a Rule 10b5-1 trading plan adopted on August 29, 2024. Following the sale, the insider directly holds 161,096 shares.
Key facts
- Insider
- Andrew D Dickinson · Chief Financial Officer
Rule 10b5-1 plan · adopted Aug 29, 2024
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | S · open-market saleFootnotes F1 | −3,000 | $156.22 | $468,660.00 | 161,096 | Direct |
Footnotes
- F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
More GILD filings
- 144
Filed Oct 30, 2026
- 8-K
Filed Oct 29, 2026
- 4
Filed Oct 16, 2026
- 144
Filed Oct 15, 2026
- 144
Filed Oct 15, 2026
- 4
Filed Oct 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.